ATE377015T1 - Verbessertes verfahren zur phosphorylierung - Google Patents

Verbessertes verfahren zur phosphorylierung

Info

Publication number
ATE377015T1
ATE377015T1 AT00924987T AT00924987T ATE377015T1 AT E377015 T1 ATE377015 T1 AT E377015T1 AT 00924987 T AT00924987 T AT 00924987T AT 00924987 T AT00924987 T AT 00924987T AT E377015 T1 ATE377015 T1 AT E377015T1
Authority
AT
Austria
Prior art keywords
phosphorylation
improved process
temperature below
intimate mixture
complex
Prior art date
Application number
AT00924987T
Other languages
English (en)
Inventor
Simon West
Original Assignee
Vital Health Sciences Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/AU2000/000038 external-priority patent/WO2000043380A1/en
Application filed by Vital Health Sciences Pty Ltd filed Critical Vital Health Sciences Pty Ltd
Application granted granted Critical
Publication of ATE377015T1 publication Critical patent/ATE377015T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/11—Esters of phosphoric acids with hydroxyalkyl compounds without further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/117—Esters of phosphoric acids with cycloaliphatic alcohols
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/12—Esters of phosphoric acids with hydroxyaryl compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6552—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
    • C07F9/65522—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65611—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system (X = CH2, O, S, NH) optionally with an additional double bond and/or substituents, e.g. penicillins and analogs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT00924987T 1999-05-14 2000-05-12 Verbessertes verfahren zur phosphorylierung ATE377015T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPQ0374A AUPQ037499A0 (en) 1999-05-14 1999-05-14 Improved process for phosphorylation and compounds produced by this method
PCT/AU2000/000038 WO2000043380A1 (en) 1999-01-25 2000-01-25 Recovery of chroman derivatives

Publications (1)

Publication Number Publication Date
ATE377015T1 true ATE377015T1 (de) 2007-11-15

Family

ID=3814578

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00924987T ATE377015T1 (de) 1999-05-14 2000-05-12 Verbessertes verfahren zur phosphorylierung

Country Status (7)

Country Link
US (1) US6579995B1 (de)
JP (1) JP4932995B2 (de)
KR (1) KR20020013876A (de)
AT (1) ATE377015T1 (de)
AU (1) AUPQ037499A0 (de)
BR (1) BR0011523B1 (de)
DE (1) DE60036940T2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR549901A0 (en) * 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
KR100612398B1 (ko) * 2000-11-14 2006-08-16 바이탈 헬스 사이언시즈 피티와이 리미티드 포스페이트 유도체의 착체
AU2002317053B2 (en) * 2001-07-27 2004-08-05 Vital Health Sciences Pty Ltd Dermal therapy using phosphate derivatives of electron transfer agents
BR0215102A (pt) * 2001-12-13 2004-11-03 Vital Health Sciences Pty Ltd Transporte transdermal de compostos, formulação tópica, método para melhorar a absorção da pele, método para a terapia de reposição hormonal, uso de um ou mais derivados de fosfato de um composto hidróxi farmacêutico em um sistema de aplicação transdermal, sistema de aplicação transdermal, método para aplicação de um composto hidróxi farmacêutico a um indivìduo e para melhorar a eficácia de uma formulação
AU2002950713A0 (en) * 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
BRPI0406484A (pt) * 2003-01-17 2005-12-06 Vital Health Sciences Pty Ltd Método de inibição da ocorrência de uma ou mais das seguintes condições: a proliferação de monócitos/macrófagos; ou a proliferação de células do músculo liso; ou a expressão de receptores de cd36; ou a absorção de lipoproteìna de baixa densidade - ldl oxidada, método de alìvio de sintomas de tratamento ou prevenção de aterosclerose; de diabetes; do mal de alzheimer, método de inibição da ocorrência da formação de placas no sistema vascular, método de alìvio da inflamação associada a ocorrência de uma ou de mais das seguintes condições: a proliferação de monócitos, a proliferação de células do músculo liso, a expressão de ldl oxidadas ou de receptor descontaminante, composição farmacêutica, uso de uma quantidade eficaz de um ou mais derivados ou fosfato de um ou mais agentes de transferência de elétrons conjuntamente com um veìculo ou um diluente apropriado, uso de uma quantidade eficaz de um ou mais derivados de fosfato de (alfa)-tocoferol conjuntamente com um veìculo ou um diluente apropriado e uso de uma quantidade eficaz de um ou mais derivados de fosfato de um ou mais agentes de transferência de elétrons selecionados do grupo que consiste em fosfato mono-tocoferila, fosfato de di-tocoferila e as misturas destes conjuntamente com um veìculo ou um diluente apropriado
AU2003901815A0 (en) * 2003-04-15 2003-05-01 Vital Health Sciences Pty Ltd Phosphate derivatives
CA2557354C (en) 2004-03-03 2013-05-07 Vital Health Sciences Pty Ltd. Alkaloid formulations
JP5198858B2 (ja) * 2004-08-03 2013-05-15 バイタル ヘルス サイエンシズ プロプライアタリー リミティド 腸内投与のための担体
WO2006092024A1 (en) * 2005-03-03 2006-09-08 Vital Health Sciences Pty Ltd Compounds having anti-cancer properties
MX2007015949A (es) * 2005-06-17 2008-03-07 Vital Health Sciences Pty Ltd Un vehiculo que comprende uno o mas derivados de fosfato de di- y/o mono-(agentes de transferencia de electrones) o complejos de los mismos.
WO2007070981A1 (en) * 2005-12-23 2007-06-28 Vital Health Sciences Pty Ltd Compounds having cytokine modulating properties
US8728990B2 (en) 2009-12-04 2014-05-20 Elementis Specialties, Inc. Phosphate ester oil gellant
US10071030B2 (en) 2010-02-05 2018-09-11 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
JP5806287B2 (ja) 2010-03-30 2015-11-10 フォスファジェニクス リミティド 経皮送達パッチ
WO2012122586A1 (en) 2011-03-15 2012-09-20 Phosphagenics Limited New composition
MX383940B (es) 2015-12-09 2025-03-14 Phosphagenics Ltd Formulación farmacéutica que contiene tocol fosfato.
JP7198754B2 (ja) * 2016-12-21 2023-01-04 アベーチョ バイオテクノロジー リミテッド 方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5022535B1 (de) * 1970-05-12 1975-07-31
JPS5239013B1 (de) * 1970-05-21 1977-10-03
US4141938A (en) 1976-10-07 1979-02-27 Hoechst Aktiengesellschaft Production of acid orthophosphoric acid ester mixtures
JPH0247997B2 (ja) 1983-02-25 1990-10-23 Sanyo Chemical Ind Ltd Rinsanesuterunoseizoho
JPS62195393A (ja) 1986-02-21 1987-08-28 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体およびその製造方法
JPS6393791A (ja) * 1986-10-08 1988-04-25 Nippon Shokubai Kagaku Kogyo Co Ltd リン酸エステルおよびその製法
DE3702766A1 (de) 1987-01-30 1988-08-11 Henkel Kgaa Verfahren zur herstellung und isolierung von monoalkylphosphorsaeureestern
IT1236843B (it) * 1989-11-22 1993-04-21 Simes Processo per la preparazione di 4-0-fosfati di dopamina o suoi derivati
US5741518A (en) * 1992-08-03 1998-04-21 L'oreal Composition composed of an aqueous dispersion of stabilized vesicles of nonionic amphiphilic lipids
US5554781A (en) * 1994-03-30 1996-09-10 Reierson; Robert L. Monoalkyl phosphonic acid ester production process
JPH07316170A (ja) 1994-05-24 1995-12-05 Kao Corp リン酸モノエステルの製造法
JP3526940B2 (ja) 1995-01-11 2004-05-17 花王株式会社 リン酸エステルの製造法
FR2730928B1 (fr) * 1995-02-23 1997-04-04 Oreal Composition a base de vesicules lipidiques a ph acide et son utilisation en application topique
JPH08231564A (ja) * 1995-02-28 1996-09-10 Nippon Shokubai Co Ltd リン酸エステルおよびその製造方法並びにリン酸エステル重合体
JP3197787B2 (ja) 1995-05-17 2001-08-13 花王株式会社 分岐二量化アルキルリン酸塩基性アミノ酸塩の製造方法
FR2741263B1 (fr) * 1995-11-22 1997-12-26 Oreal Composition comprenant une dispersion aqueuse de vesicules lipidiques encapsulant un filtre uv a fonction acide et utilisations en application topique
JPH1045783A (ja) * 1996-07-29 1998-02-17 Showa Denko Kk ヒドロキシクロマン誘導体リン酸エステルの製造方法

Also Published As

Publication number Publication date
DE60036940D1 (de) 2007-12-13
US6579995B1 (en) 2003-06-17
KR20020013876A (ko) 2002-02-21
DE60036940T2 (de) 2008-08-14
BR0011523A (pt) 2002-03-26
JP4932995B2 (ja) 2012-05-16
AUPQ037499A0 (en) 1999-06-10
JP2003526623A (ja) 2003-09-09
BR0011523B1 (pt) 2014-09-30

Similar Documents

Publication Publication Date Title
DE60036940D1 (de) Verbessertes verfahren zur phosphorylierung
ATE1242T1 (de) Verfahren zur herstellung von 3-amino-1-hydroxypropan-1,1-diphosphonsaeure.
HUP9900664A2 (hu) Eljárás N-(foszfono-metil)-imino-diecetsav előállítására
JP2003526623A5 (de)
ATE316975T1 (de) Verfahren zur herstellung von ethanbis(methylphosphinsäure)
Al-Madfa et al. Phosphorus-nitrogen compounds. Part 64.1 the reactions of hexachlorocyclotriphosphazatriene with 2, 2-dimethylpropane-1, 3-diol. nuclear magnetic resonance studies of the products
DK589484D0 (da) Fremgangsmaade til udvinding af vancomycin fra en vandig oploesning heraf
MY106953A (en) Process for synthesis of aminomethylene phosphonoalkylphosphinates
DK0693074T3 (da) Fremgangsmåde til fremstilling af aminomethanphosphonsyre
ATE269346T1 (de) Verfahren zur herstellung von spirobisphosphiten
EP1095047A4 (de) Zubereitungen von thiophosphiten und thiophosphonaten
Terent'eva et al. Reaction of 2-ethyl-4, 5-benzo-1, 3, 2-oxazaphospholane with mercaptans
Blonski et al. Models of biotin coenzyme reactions activated through phosphorylation
ATE1147T1 (de) Verhinderung von feststoffabscheidungen in methyldichlorphosphan enthaltenden gemischen.
JPS6422823A (en) Antiulcer agent
ES484569A1 (es) Procedimiento para preparar una composicion insecticida a base de fosfatos y fosfanatos de pirazol.
DE69209258D1 (de) Verfahren zur Herstellung von Dichlormethylpyridinen
Yan et al. STUDIES ON DIASTEREOMERIC N-PHOSPHONOAMINO ACID ESTERS CONTAINING A PHOSPHORUS-CARBON BOND
JPS5679697A (en) Production of phosphoric ester
JPS5318519A (en) Isolation of tris (trialkylsilyl) phosphite
KR900000374A (ko) N-포스포노메틸 글리신의 제조방법
DE69012835D1 (de) Verfahren zur herstellung von sterisch gehinderten arylphosphiten.
JPS5225798A (en) Process for preparing 1,n6-etheno-2- amino-adenosine-3'5'-cyclic phosp hate
GB784985A (en) Manufacture of organic phosphorus compounds
ES460183A1 (es) Procedimiento para la obtencion de amidas-esteres o-(1-fluo-ro-2-halogeno-etilicos) de los acidos (tiono)-fosfo-ricos (-nicos).

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties